Vishuo Biomedical

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Vishuo Biomedical

Vishuo Biomedical is a Singapore based healthcare technology company dedicated to establish personalized medicine for prognosis, diagnosis and treatment. It delivers genomic sequence analysis to research institutes, health screening clinics, hospitals and pharmaceutical industry. Since 2012, our products and services have been dominating the biomedical market in China. The iCMDB platform has been applied to multiple grade 3 and first-tier hospitals. Our analysis workflow was further reinforced through establishing sequencing facilities in these collaborating hospitals. In 2014, iCMDB was certified by ISO13485:2003, and classified as Class A medical device by Singapore HSA.